Cannabis use disorder rising among US adults, study finds
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyPolicyAgingPainAnxiety Why This Matters I notice the summary provided appears to be incomplete…
Marijuana’s menace: cannabis use disorder spiking, study says
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyPolicyTHCNeurologyAnxiety Why This Matters Clinicians need to understand that cannabis use…
A Look at More Than 30 Cannabis and Cannabinoid Clinical Trials Published in 2026
This systematic review cannabis clinical trials 2026 highlights over 30 studies demonstrating modest but statistically significant therapeutic effects of cannabinoids. The evidence supports cautious clinical use with generally favorable safety profiles.…
Canada’s New Cannabis Brain Health Research Consortium
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicyNeurologyMental HealthSafetyAnxietyCBD Why This Matters This consortium addresses a critical clinical gap…
Government of Canada investing $24 million to establish cannabis and brain health …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchNeurologyMental HealthSafetyAnxietySleep Why This Matters Canadian clinicians need evidence on…
Healing without the High: Elizabeth Mack, RN on the Power of Cannabino – Dr. Clark Store
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDTHCNeurologyResearchSafetyAgingPain Why This Matters Clinicians treating neurodegenerative diseases need to understand…
Medicinal cannabis prescriptions surge to more than 72,000 in a year
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainPolicyResearchSafetyIndustryNeurologyMental Health Why This Matters Clinicians need to understand this surge in…
PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for …
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyPainAnxietyMental HealthIndustryNeurology Why This Matters This NIDA-funded Phase 3 trial represents…
Ireland Finds High-Risk Synthetic Cannabinoids in CBD and Cannabis Products
Ireland synthetic cannabinoid warning: Ireland's health service found high-risk synthetic and semi-synthetic cannabinoids in tested vapes and vape liquids. Products sold as CBD, cannabis, or THC may not match their labels. The report supports product…
Health Risks and Emergency Treatment of Synthetic Cannabinoids
Synthetic cannabinoids toxicity emergency treatment is critical due to their severe health risks. These compounds cause acute psychiatric symptoms, cardiovascular complications, and seizures. Clinicians must recognize these dangers and tailor treatment…